Techne Corp (TECH) 90.79 $TECH
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: MCGC, TECH, TER
at The Street - Tue May 06, 9:00AM CDT
MCGC TECH TER are going ex-dividend tomorrow, Wednesday, May 7, 2014, 4:00 AM ET
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AstraZeneca PLC (NYSE: AZN), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX), GW Pharmaceuticals plc (NASDAQ: GWPH), Techne Corp. (NASDAQ: TECH) and Agenus Inc. (NASDAQ: AGEN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1869-100free.
Bio-Techne's board to pay dividend to holders of record as of 9 May 2014
M2 - Tue Apr 29, 3:44AM CDT
The board of directors of Techne (Bio-Techne) (Nasdaq:TECH), a life sciences company, declared on Monday its dividend of USD0.31 per share of its common stock for the quarter ended 31 March 2014.
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Techne (TECH) Stock Is Up Today
at The Street - Mon Apr 28, 12:19PM CDT
Techne (TECH) shares are up 5.4% after beating analysts earnings and revenue guidance in its third quarter 2014 earnings report.
Bio-Techne Declares Dividend
PR Newswire - Mon Apr 28, 6:00AM CDT
Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne announced that its Board of Directors has decided to pay a dividend of $0.31 per share for the quarter ended March 31, 2014. The quarterly dividend will be payable May 23, 2014 to all common shareholders of record on May 9, 2014. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
Bio-Techne Releases Unaudited Third Quarter And Nine Month Fiscal Year 2014 Results
PR Newswire - Mon Apr 28, 6:00AM CDT
Techne Corporation's (NASDAQ:TECH), (d/b/a Bio-Techne) financial results for the third quarter and nine months ended March 31, 2014 include the following highlights:
Tauriga Sciences Inc. Raises More than 1 Million in Private Placement
ACCESSWIRE - Sat Apr 26, 9:17AM CDT
Tauriga Sciences Inc.'s (OTCQB: TAUG) enjoyed strong volume Apr. 24, with 8,234,091 shares changing hands.
Bio-Techne To Host Conference Call On April 28, 2014 To Announce Third Quarter Financial Results
PR Newswire - Mon Apr 21, 7:00AM CDT
Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, today announced that management will host a conference call on Monday, April 28, 2014, at 7:30 a.m. CDT to review third quarter fiscal 2014 financial results.
Bio-Techne to acquire 100% ownership interest of PrimeGene in cash
M2 - Wed Apr 16, 3:49AM CDT
Biotechnology products Techne (NasdaqGS:TECH) reported on Tuesday the launch of an agreement to acquire 100% of the ownership interest of Shanghai PrimeGene Bio-Tech Co (PrimeGene) in cash.
Bio-Techne Announces Acquisition Agreement
PR Newswire - Tue Apr 15, 7:00AM CDT
Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that its R&D Systems China Co. Ltd. (R&D China) subsidiary has entered into an agreement to acquire 100% of the ownership interest of Shanghai PrimeGene Bio-Tech Co. (PrimeGene). PrimeGene is a leader in the China market in the development, manufacture and distribution of recombinant proteins for research and diagnostic applications. The transaction is expected to close in the fourth quarter of fiscal 2014, subject to the satisfaction of certain closing conditions. The acquisition is not subject to any financing contingencies.
Techne Downgraded to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 2:30PM CDT
Techne has witnessed sharp downward estimate revisions after reporting its second-quarter fiscal 2014 results.
Healthsense Names Greg Melsen Chief Financial Officer
Marketwire - Thu Mar 06, 10:32AM CST
Healthsense, Inc., the fastest growing provider of technology-enabled care solutions for the senior care continuum, announced today that Greg Melsen has joined the company as Chief Financial Officer.
Post Earnings Update: Techne Has Climbed 4.5% Higher in Past 2 Weeks (TECH)
Comtex SmarTrend(R) - Mon Feb 24, 7:19AM CST
When Techne (NASDAQ:TECH) reported earnings two weeks ago on February 4th, 2014, analysts, on average, expected the company to report earnings of $0.80 on sales of $84.6 million. The company actually reported EPS of $0.75 on sales of $84.0 million, missing EPS estimates by $0.05 and missing revenue estimates by $0.6 million. Shares of Techne have climbed from $85.08 to $88.89, representing a gain of 4.5% since the company reported earnings 20 days ago.
Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Tue Feb 11, 7:04AM CST
Techne (NASDAQ:TECH) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $88.56 on volume of 398,000 shares, above average daily volume of 277,000. Over the past year, Techne has traded in a range of $62.55 to $96.96 and closed yesterday at $88.56, 42% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has remained constant.
Techne Corporation reports launch of new trade name, Bio-Techne
M2 - Tue Feb 11, 5:07AM CST
Biotechnology products company Techne Corporation (NasdaqGS:TECH) stated on Monday that all of its products will be operating under the new corporate trade name, Bio-Techne.
Techne Corporation Announces New Trade Name, Bio-Techne
PR Newswire - Mon Feb 10, 6:00AM CST
Techne Corporation (NASDAQ: TECH) announced today that it will be operating under the new trade name, Bio-Techne. The use of Bio-Techne will bring the company's R&D Systems, BiosPacific, Tocris Biosciences, Boston Biochem and Bionostics products under one common brand name.
3 Tech Stocks Under $10 to Watch
at The Street - Fri Feb 07, 8:27AM CST
Keep these under-$10 tech stocks on your radar.
Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: MCGC, TECH, TER
at The Street - Tue May 06, 9:00AM CDT
MCGC TECH TER are going ex-dividend tomorrow, Wednesday, May 7, 2014, 4:00 AM ET
Earnings Results, Acquisitions, Drug Designations, Dividend Authorizations, and Licensing Agreements - Analyst Notes on AstraZeneca, Furiex, GW, Techne and Agenus
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding AstraZeneca PLC (NYSE: AZN), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX), GW Pharmaceuticals plc (NASDAQ: GWPH), Techne Corp. (NASDAQ: TECH) and Agenus Inc. (NASDAQ: AGEN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1869-100free.
Bio-Techne's board to pay dividend to holders of record as of 9 May 2014
M2 - Tue Apr 29, 3:44AM CDT
The board of directors of Techne (Bio-Techne) (Nasdaq:TECH), a life sciences company, declared on Monday its dividend of USD0.31 per share of its common stock for the quarter ended 31 March 2014.
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Techne (TECH) Stock Is Up Today
at The Street - Mon Apr 28, 12:19PM CDT
Techne (TECH) shares are up 5.4% after beating analysts earnings and revenue guidance in its third quarter 2014 earnings report.
Bio-Techne Declares Dividend
PR Newswire - Mon Apr 28, 6:00AM CDT
Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne announced that its Board of Directors has decided to pay a dividend of $0.31 per share for the quarter ended March 31, 2014. The quarterly dividend will be payable May 23, 2014 to all common shareholders of record on May 9, 2014. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
Bio-Techne Releases Unaudited Third Quarter And Nine Month Fiscal Year 2014 Results
PR Newswire - Mon Apr 28, 6:00AM CDT
Techne Corporation's (NASDAQ:TECH), (d/b/a Bio-Techne) financial results for the third quarter and nine months ended March 31, 2014 include the following highlights:
Tauriga Sciences Inc. Raises More than 1 Million in Private Placement
ACCESSWIRE - Sat Apr 26, 9:17AM CDT
Tauriga Sciences Inc.'s (OTCQB: TAUG) enjoyed strong volume Apr. 24, with 8,234,091 shares changing hands.
Bio-Techne To Host Conference Call On April 28, 2014 To Announce Third Quarter Financial Results
PR Newswire - Mon Apr 21, 7:00AM CDT
Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, today announced that management will host a conference call on Monday, April 28, 2014, at 7:30 a.m. CDT to review third quarter fiscal 2014 financial results.
Bio-Techne to acquire 100% ownership interest of PrimeGene in cash
M2 - Wed Apr 16, 3:49AM CDT
Biotechnology products Techne (NasdaqGS:TECH) reported on Tuesday the launch of an agreement to acquire 100% of the ownership interest of Shanghai PrimeGene Bio-Tech Co (PrimeGene) in cash.
Bio-Techne Announces Acquisition Agreement
PR Newswire - Tue Apr 15, 7:00AM CDT
Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne) announced today that its R&D Systems China Co. Ltd. (R&D China) subsidiary has entered into an agreement to acquire 100% of the ownership interest of Shanghai PrimeGene Bio-Tech Co. (PrimeGene). PrimeGene is a leader in the China market in the development, manufacture and distribution of recombinant proteins for research and diagnostic applications. The transaction is expected to close in the fourth quarter of fiscal 2014, subject to the satisfaction of certain closing conditions. The acquisition is not subject to any financing contingencies.
Techne Downgraded to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 2:30PM CDT
Techne has witnessed sharp downward estimate revisions after reporting its second-quarter fiscal 2014 results.
Healthsense Names Greg Melsen Chief Financial Officer
Marketwire - Thu Mar 06, 10:32AM CST
Healthsense, Inc., the fastest growing provider of technology-enabled care solutions for the senior care continuum, announced today that Greg Melsen has joined the company as Chief Financial Officer.
Post Earnings Update: Techne Has Climbed 4.5% Higher in Past 2 Weeks (TECH)
Comtex SmarTrend(R) - Mon Feb 24, 7:19AM CST
When Techne (NASDAQ:TECH) reported earnings two weeks ago on February 4th, 2014, analysts, on average, expected the company to report earnings of $0.80 on sales of $84.6 million. The company actually reported EPS of $0.75 on sales of $84.0 million, missing EPS estimates by $0.05 and missing revenue estimates by $0.6 million. Shares of Techne have climbed from $85.08 to $88.89, representing a gain of 4.5% since the company reported earnings 20 days ago.
Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Tue Feb 11, 7:04AM CST
Techne (NASDAQ:TECH) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $88.56 on volume of 398,000 shares, above average daily volume of 277,000. Over the past year, Techne has traded in a range of $62.55 to $96.96 and closed yesterday at $88.56, 42% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has remained constant.
Techne Corporation reports launch of new trade name, Bio-Techne
M2 - Tue Feb 11, 5:07AM CST
Biotechnology products company Techne Corporation (NasdaqGS:TECH) stated on Monday that all of its products will be operating under the new corporate trade name, Bio-Techne.
Techne Corporation Announces New Trade Name, Bio-Techne
PR Newswire - Mon Feb 10, 6:00AM CST
Techne Corporation (NASDAQ: TECH) announced today that it will be operating under the new trade name, Bio-Techne. The use of Bio-Techne will bring the company's R&D Systems, BiosPacific, Tocris Biosciences, Boston Biochem and Bionostics products under one common brand name.
3 Tech Stocks Under $10 to Watch
at The Street - Fri Feb 07, 8:27AM CST
Keep these under-$10 tech stocks on your radar.
